UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models

Cell host & microbe, 2021-02, Vol.29 (2), p.236-249.e6

2021

Volltextzugriff (PDF)

Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters

Scientific reports, 2022-04, Vol.12 (1), p.6570-6570, Article 6570

2022

Volltextzugriff (PDF)

Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice

EMBO molecular medicine, 2021-12, Vol.13 (12), p.e14459-n/a

2021

Volltextzugriff (PDF)

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa

Molecular therapy, 2022-09, Vol.30 (9), p.2984-2997

2022

Volltextzugriff (PDF)

Biophysical virus particle specific characterization to sharpen the definition of virus stability

European journal of pharmaceutics and biopharmaceutics, 2018-11, Vol.132, p.62-69

2018

Volltextzugriff (PDF)

Transfusion-Transmitted Yersinia enterocolitica Sepsis

Clinical infectious diseases, 2011-09, Vol.53 (6), p.583-591

2011

Volltextzugriff (PDF)

Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication

Microbes and infection, 2023-09, Vol.25 (7), p.105142-105142, Article 105142

2023

Volltextzugriff (PDF)

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4 + T-cell immunity

Mucosal immunology, 2022-06, Vol.15 (6), p.1389-1404

2022

Volltextzugriff (PDF)

Impact on the host of the Yersinia pestis-specific virulence set and the contribution of the pla surface protease

Advances in experimental medicine and biology, 2012, Vol.954, p.211

2012

Volltextzugriff (PDF)

Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P. falciparum

Nature (London), 2000-10, Vol.407 (6807), p.1018-1022

2000

Volltextzugriff (PDF)

Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague: e1005222

PLoS pathogens, 2015-10, Vol.11 (10)

2015

Volltextzugriff (PDF)

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults

Human vaccines & immunotherapeutics, 2023-12, Vol.19 (3), p.2275453-2275453

2023

Volltextzugriff (PDF)

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phase II pre-exposure prophylaxis regimen study

Vaccine, 2022-08, Vol.40 (35), p.5170-5178

2022

Volltextzugriff (PDF)

Immunogenicity and Safety of a Purified Vero Rabies Vaccine—Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial

Clinical infectious diseases, 2024-06, Vol.78 (6), p.1748-1756

2024

Volltextzugriff (PDF)

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study

Vaccine, 2022-08, Vol.40 (33), p.4780-4787

2022

Volltextzugriff (PDF)

A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity

Cell reports (Cambridge), 2022-07, Vol.40 (4), p.111142-111142, Article 111142

2022

Volltextzugriff (PDF)

Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague

PLoS pathogens, 2015-10, Vol.11 (10), p.e1005222-e1005222

2015

Volltextzugriff (PDF)

Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA – Results of an international collaborative study

Vaccine, 2017-02, Vol.35 (6), p.966-971

2017

Volltextzugriff (PDF)

Should we still fear the plague today?

M.S. Médecine sciences, 2008-10, Vol.24 (10), p.865

2008

Volltextzugriff (PDF)

Defective innate cell response and lymph node infiltration specify Yersinia pestis infection

PloS one, 2008-02, Vol.3 (2), p.e1688-e1688

2008

Volltextzugriff (PDF)

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

Vaccines (Basel), 2023-01, Vol.11 (1), p.12

2023

Volltextzugriff (PDF)

A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab™ for pre-exposure use in healthy adults: Results from a randomized controlled phase-II trial

Vaccine, 2013-04, Vol.31 (18), p.2295-2301

2013

Volltextzugriff (PDF)

A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China

Vaccine, 2013-12, Vol.31 (50), p.5940-5947

2013

Volltextzugriff (PDF)

Detection of Yersinia pestis in Sputum by Real-Time PCR

Journal of Clinical Microbiology, 2003-10, Vol.41 (10), p.4873-4875

2003

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(55)

Sprache

Englisch
(51)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(41)
Animals
(24)
Humans
(23)
Immunology
(15)
Biological And Medical Sciences
(14)
Female
(13)
Male
(13)
Medicine, Research & Experimental
(13)
Mice
(13)
Research & Experimental Medicine
(13)
Fundamental And Applied Biological Sciences. Psychology
(12)
Life Sciences
(12)
Microbiology
(12)
Vaccines
(11)
Biochemistry & Molecular Biology
(9)
Immunogenicity
(9)
Rabies
(9)
Middle Aged
(8)
Vaccination
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models

Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters

Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model

Biophysical virus particle specific characterization to sharpen the definition of virus stability

Transfusion-Transmitted Yersinia enterocolitica Sepsis

Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4 + T-cell immunity

Impact on the host of the Yersinia pestis-specific virulence set and the contribution of the pla surface protease

Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P. falciparum

Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague: e1005222

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phase II pre-exposure prophylaxis regimen study

Immunogenicity and Safety of a Purified Vero Rabies Vaccine—Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study

A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity

Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague

Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA – Results of an international collaborative study

Should we still fear the plague today?

Defective innate cell response and lymph node infiltration specify Yersinia pestis infection

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab™ for pre-exposure use in healthy adults: Results from a randomized controlled phase-II trial

A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China

Detection of Yersinia pestis in Sputum by Real-Time PCR

Suchergebnisse filtern